Elizabeth A. Allen
Lausanne Branch
Lausanne, VD, Switzerland
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A new effLuc/Kate dual reporter allele for tumor imaging in mice.
Journal: Disease models & mechanisms
Published: September 30, 2024
Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts.
Journal: Journal of breath research
Published: July 05, 2024
Piloting the adaptation of the Kaufman Assessment Battery for Children-2 nd edition (KABC-II) to assess school-age neurodevelopment in rural Zimbabwe.
Journal: Wellcome open research
Published: May 20, 2024
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop.
Journal: Cancer cell
Published: January 10, 2023
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop.
Journal: Cancer cell
Published: December 23, 2021
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2020
Consensus guidelines for the use and interpretation of angiogenesis assays.
Journal: Angiogenesis
Published: May 17, 2018
Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors.
Journal: Oncotarget
Published: October 09, 2017
Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations.
Journal: Cold Spring Harbor symposia on quantitative biology
Published: April 12, 2017
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.
Journal: Science translational medicine
Published: September 21, 2016
Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging.
Journal: PloS one
Published: February 25, 2015
Last Updated: 09/26/2026